ACELYRIN
SLRN
SLRN was delisted on the 21st of May, 2025.
113 hedge funds and large institutions have $384M invested in ACELYRIN in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 21 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 25
24% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 21
4% more funds holding
Funds holding: 109 → 113 (+4)
5.48% less ownership
Funds ownership: 93.35% → 87.87% (-5.5%)
19% less call options, than puts
Call options by funds: $47K | Put options by funds: $58K
37% less capital invested
Capital invested by funds: $613M → $384M (-$229M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$5.78M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$4.52M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.19M |
| 4 |
Millennium Management
New York
|
+$2.95M |
| 5 |
Morgan Stanley
New York
|
+$2.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$9.14M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.81M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7M |
| 5 |
VA
VR Adviser
New York
|
-$6.33M |
SLRN Hedge Fund Activity: Q2 2024 in Review
113 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q2 2024, worth a combined $384M — down 37% from $613M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new SLRN positions and 21 closed out — a net gain of 5 holders — while 45 added to existing stakes and 25 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $5.78M. The largest seller was Fidelity Investments, cutting an estimated $11.1M.
- 113 institutional investors held ACELYRIN (SLRN) as of Q2 2024, up from 109 in Q1 2024.
- Funds reported $384M of ACELYRIN stock for Q2 2024, down 37% quarter-over-quarter.
- 26 funds opened new ACELYRIN positions in Q2 2024 and 21 closed out, a net change of +5 holders.
- The largest ACELYRIN buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $5.78M added.
- The largest ACELYRIN seller in Q2 2024 was Fidelity Investments, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2024.